Identification of Achromobacter xylosoxidans by detection of the blaOXA-114-like gene intrinsic in this species

Diagnostic Microbiology and Infectious Disease

Volumn 70, Issue 3, 2011, Pages 408-411

  Turton, Jane F ^a   Mustafa, Nazim ^a   Shah, Jayesh ^a   Hampton, Catherine V ^a   Pike, Rachel ^a   Kenna, Dervla T ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Achromobacter xylosoxidans; BlaOXA 114 like; Pulsed field gel electrophoresis

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL PROTEIN; BLAOXA 114 LIKE PROTEIN; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULBACTAM; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACHROMOBACTER XYLOSOXIDANS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLAOXA 114 LIKE GENE; CONTROLLED STUDY; CROSS INFECTION; GENE SEQUENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ACHROMOBACTER DENITRIFICANS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 79959256137     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.02.007     Document Type: Article

References (10)

1. Coutinho H.D.M., Falcão-Silva V.S., Gonçalves G.F. Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers. Int. Arch. Med. 2008, 1:24.
2. De Baets F., Schelstraete P., Van Daele S., Haerynck F., Vaneechoutte M. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 2007, 6:75-78.
3. Doi Y., Poirel L., Paterson D.L., Nordmann P. Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans. Antimicrob. Agents Chemother. 2008, 52:1952-1956.
4. Emerson J., McNamara S., Buccat A.M., Worrell K., Burns J.L. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatr. Pulmonol. 2010, 45:363-370.
5. Hansen C.R., Pressler T., Nielsen K.G., Jensen P.Ø., Bjarnsholt T., Høiby N. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 2010, 9:51-58.
6. Kanellopoulou M., Pournaras S., Iglezos H., Skarmoutsou N., Papafrangas E., Maniatis A.N. Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone. Eur. J. Clin. Microbiol. Infect Dis. 2004, 23:336-339.
7. Liu L., Coenye T., Burns J.L., Whitby P.W., Stull T.L., LiPuma J.J. Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J. Clin. Microbiol. 2002, 40:1210-1213.
8. Magni A., Trancassini M., Varesi P., Iebba V., Curci A., Pecoraro C., Cimino G., Schippa S., Quattrucci S. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles of cystic fibrosis patients. J. Clin. Microbiol. 2010, 48:1035-1039.
9. Turton J.F., Kaufmann M.E., Mustafa N., Kawa S., Clode F.E., Pitt T.L. Molecular comparison of isolates of Burkholderia multivorans from patients with cystic fibrosis in the United Kingdom. J. Clin. Microbiol. 2003, 41:5750-5754.
10. Van Daele S., Verhelst R., Claeys G., Verschraegen G., Franckx H., Van Simaey L., de Ganck C., De Baets F., Vaneechoutte M. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center. J. Clin. Microbiol. 2005, 43:2998-3002.